Clinical Trial Update: Cipralex® for Anxiety Disorders in Adolescents [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating Cipralex (escitalopram) for anxiety disorders in adolescents. The study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Cipralex (citalopram)

Snippet

Sponsor: University of Ottawa | Conditions: Anxiety Disorder | Phase 1 | Status: UNKNOWN